Globe Newswire
Madrid, 22 May. - Revenues at listed technology company Lleida.net (OTCQX:LLEIF) (BME:LLN) (EPA:ALLLN) rose seven per cent in the first four months of 2024, compared to the same period last year.
In the period, the company sold certified e-notification, e-recruitment and e-signature services along with SMS solutions worth €6.3 million, up from €5.88 million in the first months of 2023.
The company's cumulative EBITDA increased by 170% to 888 thousand euros,... (continue reading...)
The Company on 22 May 2024 through a public offer led by Luminor Bank has successfully distributed an additional 2.99 MEUR Green Bonds issue at 10.0% yield under Company’s 100 MEUR Note Programme. This deal signifies the completion of this landmark programme in the Baltic markets set up under the Green Bond Framework.
Additionally issued bonds will be fungible with already issued bonds under ISIN LT0000405938. The bonds were subscribed by individuals and legal... (continue reading...)
22 May 2024
Notification no. 53/2024
Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation.
In connection with the share buy-back program in Danske Bank A/S, APMH Invest A/S continuously sells shares pro rata.
For further details, please find the attached templates for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons... (continue reading...)
VANCOUVER, British Columbia, May 22, 2024 (GLOBE NEWSWIRE) -- Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), is pleased to announce that it has purchased approximately 7.7 acres of land located immediately adjacent to important surface infrastructure at its 100% owned and permitted South Crofty tin project in Cornwall, United Kingdom.
Ken Armstrong, Interim CEO and Director of Cornish Metals, stated: “The acquisition of this... (continue reading...)
WARMINSTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that two abstracts have been accepted for poster and oral presentations at the European Association for the Study of the Liver (EASL) Congress 2024... (continue reading...)
More Globe Newswire
View Older Stories-
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
-
Equinor ASA: Share buy-back
-
GOGL – First Quarter 2024 Results
-
GTT: Terms of availability of preparatory documents for the combined general meeting of shareholders on June 12, 2024
-
Transaction in own shares
-
KBC Group: Update regarding the KBC Group share buyback programme
-
A Report on the Topics to be Covered in the Webinar
-
Novaturas Group earned EUR 34.5 mln. in the first quarter
-
Novaturas Group earned EUR 34.5 mln. in the first quarter
-
Transaction in Own Shares
-
Nextensa offers its shareholders an optional dividend
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
-
Aalberts N.V.: Aalberts sustained added value margin in challenging market environment
-
Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, Belgium
-
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
-
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe
-
Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk
-
Start of Day Message
-
Hexagon Purus to supply Toyota Motor North America for serial production of heavy-duty fuel cell electric powertrain kits
-
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
-
Wereldhave was assigned Long-Term Issuer Default Rating and senior unsecured rating of ‘BBB’ from Fitch Ratings
-
Predicine to Present 9 Liquid Biopsy Studies at ASCO 2024
-
Flash News: OKX Wallet Now Integrated with Thruster, a DeFi Protocol on Blast
-
IIHS, Consumer Reports name safe, affordable vehicles for teens
-
Deenova enters Belgian market with tender win at AZ Saint Lucas Hospital
-
Oceana Calls on Coca-Cola’s Largest Bottler to Commit to Reuse and Plastic Reduction
-
LifeStance Health Group Announces Pricing of Secondary Public Offering
-
Falco Thanks the Community for Its Participation at the BAPE Public Information Session
-
Flash News: OKX Wallet Now Integrated with Birdeye, a Leading Crypto Trading Data Aggregator
-
NARI Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Inari Medical, Inc. Securities Fraud Class Action
-
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
TELADOC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Teladoc Health, Inc. and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Ocugen, Sonder, and QuidelOrtho Innovations and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Globe Life and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UnitedHealth, and Vestis and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Equinix, Harbor Diversified, and Altimmune and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Perion, SpaceMobile, Sharecare, and Rivian and Encourages Investors to Contact the Firm
-
SHIMMICK ALERT: Bragar Eagel & Squire, P.C. is Investigating Shimmick Corporation on Behalf of Shimmick Stockholders and Encourages Investors to Contact the Firm
-
Tsingtao Beer Museum Selected as One of China's Top 100 Museums with Overseas Influence
-
Tsingtao Beer Museum Selected as One of China's Top 100 Museums with Overseas Influence
-
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
-
Imperial Drilling Intersects 257.5 Metres Grading 0.71% Copper and 0.39 g/t Gold at Mount Polley
-
June 4th Lead Plaintiff Deadline Approaching in Class Action Against Checkpoint Therapeutics, Inc. – Contact Robbins LLP Today
-
Globe Life, Inc. Class Action Notification: Contact Robbins LLP for Information About Your Rights Against GL
-
Carbon Streaming Announces Landmark Azuero Reforestation Carbon Removal Project in Collaboration With Rubicon Carbon, Ponterra, and Microsoft
-
Prison Fellowship Praises U.S. House of Representatives for Passing the Federal Prison Oversight Act
-
Verisk Analytics, Inc. Prices Offering of Senior Notes
-
Hudbay Announces Election of Directors
